IJCRR - 13(16), August, 2021
Pages: 198-206
In Silico Screening of Phytochemicals of Styrax Benzoin Against the Inflammatory Mediators
Author: Swathy B, Menaka M, Kiran G, Prabhakar Reddy V
Category: Healthcare
[Download PDF]
Abstract:
Introduction: Inflammatory mediators are up-regulated during SARS-CoV-2 infection and also during injury and surgery. The wound is categorized as break down or opening of the skin, which could lead to malfunctioning of skin. Many physiological processes, protein targets, and cellular signalling pathways are involved in wound healing. Many inflammatory mediators are produced during injury and inhibition of the negative inflammatory mediators like 1RAK4 and NLRP3 inflammasome plays a key role in the wound healing process. Therefore, it could essential to find therapeutics for inhibiting the signalling pathways responsible for the release of negative inflammatory mediators. However, the conventional approaches to drug development are time-consuming and expensive. Objective: In the present study, we have adopted a computational approach to identify lead molecules from Styrax Benzoinagainst the inflammatory mediators. Method: We have screened ligands from Styrax Benzoin library for their ability to bind and inhibit the two potential inflammatory targets such as IRAK4 (Interleukin-1 Receptor Associated Kinase-4) with Protein Data Bank (6F3I) and innate immune signalling receptor NLRP3 (NOD-, LRR-, and pyrin domain-containing-3) inflammasome with Protein Data Bank (6NPY). Results: We found that p-coumarin cinnamate 6 and coniferyl benzoate 12 could bind at the substrate-binding pocket of inflammatory targets with high binding affinity. Bioavailability properties and Pharmacophore features were also studied. Conclusion: The results suggest that the Phytoconstituents of Styrax Benzoin have the potential to be developed as novel inhibitors of inflammatory mediators. These inflammatory mediators are upregulated during SARS-CoV-2 infections. However, their clinical usage on wound healing is a subject of further investigations and clinical trials.
Keywords: Styrax Benzoin, Inflammatory Mediators, SARS-CoV-2, Wound, 1RAK4, NLRP3 inflammasome
Citation:
Swathy B, Menaka M, Kiran G, Prabhakar Reddy V. In Silico Screening of Phytochemicals of Styrax Benzoin Against the Inflammatory Mediators International Journal of Current Research and Review. 13(16), August, 198-206
References:
1. WHS 2019 Abstracts. Wound Repair and Regeneration. 2019;27(3): A1-A40.
2. Velnar T, Bailey T, Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J. Int. Med. Res. 2009;37(5):1528-42.
3. Bertone AL. Principles of wound healing. Vet. Clin. North. Am. Equine. Pract. 1989 Dec 1;5(3):449-63.
4. George Broughton I, Janis JE, Attinger CE. The basic science of wound healing. Plast Reconstr Surg. 2006;117(7S):12S-34S.
5. Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J. Leukoc. Biol. 2001;69(4):513-21.
6. Fara A, Mitrev Z, Rosalia RA, Assas BM. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines. Open. Biol. 2020;10(9):200160.
7. Bai B, Yang Y, Wang Q, Li M, Tian C, Liu Y, et al. NLRP3 inflammasome in endothelial dysfunction. Cell. Death. Dis.. 2020;11(9):1-18.
8. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol.Rev. 2003.
9. Fujiwara N, Kobayashi K. Macrophages in inflammation. Curr.Drug.Targ-Inflam Allergy. 2005;4(3):281-6.
10. Raja SK, Garcia MS, Isseroff RR. Wound re-epithelialization: modulating keratinocyte migration in wound healing. Front. Biosci. 2007;12(3):2849-68.
11. Baum CL, Arpey CJ. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatologic surgery. 2005;31(6):674-86.
12. Weinheimer-Haus EM, Mirza RE, Koh TJ. Nod-like receptor protein-3 inflammasome plays an important role during early stages of wound healing. PLoS One. 2015;10(3):e0119106.
13. Shen H-H, Yang Y-X, Meng X, Luo X-Y, Li X-M, Shuai Z-W, et al. NLRP3: a promising therapeutic target for autoimmune diseases. Autoimmun Rev. 2018;17(7):694-702.
14. Zhang X, Dai J, Li L, Chen H, Chai Y. NLRP3 inflammasome expression and signaling in human diabetic wounds and in high glucose-induced macrophages. J Diabetes Res. 2017;2017.
15. Katsuyama E, Miyamoto H, Kobayashi T, Sato Y, Hao W, Kanagawa H, et al. Interleukin-1 receptor-associated kinase-4 (IRAK4) promotes inflammatory osteolysis by activating osteoclasts and inhibiting formation of foreign body giant cells. J.Bio.Chem. 2015;290(2):716-26.
16. Patra MC, Choi S. Recent progress in the molecular recognition and therapeutic importance of interleukin-1 receptor-associated kinase 4. Molecules. 2016;21(11):1529.
17. Borges T. Clinical Approach to Systemic Autoinflammatory Disorders: Classification, Disease Phenotypes and Management. Curr. Imm. Rev. 2018;14(2):105-19.
18. Zarrin AA, Bao K, Lupardus P, Vucic D. Kinase inhibition in autoimmunity and inflammation. Nat. Rev. Drug. Discov. 2020:1-25.
19. Sankaralingam R, Sengottuvelan B, Venkat P, Selvaraj M, Arunachalam V, Natarajan J. Experimental investigation on varying flame characteristics of benzoic resin solid fuel pellets. Renewable Energy. 2020;147:1500-10.
20. Saputra MH, Sagala SAH, Lee HS, editors. Species Distribution of Styrax sumatrana in North Sumatra using Maxent Modelling Approach. Forum Geografi; 2020.
21. Falzon CC, Balabanova A. Phytotherapy: An Introduction to Herbal Medicine. Prim Care. 2017 Jun;44(2):217-227.
22. Wang F, Zhang L, Zhang Q, Chen A, Wang S, Fang Z. Two new phenylpropanoids from the resin of Styrax tonkinensis (Pierre) Craib ex Hartw. J Nat Med. 2020:1-6.
23. Tra NT, Anh TD, Van Cuong P, Ha NTT, Anh LTT, Cham BT, et al. Chemical constituents from the leaves of Styrax annamensis Guill. Vietnam J. Chem. 2020;58(5):630-6.
24. Nurwahyuni I, Situmorang M, Sinaga R. Plant Regeneration through Callus Cultures from Leaf Explant of Sumatra Benzoin (Styrax benzoin). Int J Forestry Res. 2020;2020.
25. Jaradat N. Phytochemistry, traditional uses and biological effects of the desert plant Styrax officinalis L. J.Arid. Env. 2020;182:104253.
26. Atia Sharif HN, Rehman R, Mushtaq A, Rashid U. A review on bioactive potential of Benzoin Resin. Int. J. of Chem. Biochem. Sci. 2016;10(1):106-10.
27. Du J, Singh H, Yi TH. Antibacterial, anti-biofilm and anticancer potentials of green synthesized silver nanoparticles using benzoin gum (Styrax benzoin) extract. Bioprocess Biosyst Eng. 2016;39(12):1923-1931.
28. Parkman C. Integrating CAM into traditional health care. The Case. Manager. 2000;11(3):27-9.
29. Degorce SL, Anjum R, Dillman KS, Drew L, Groombridge SD, Halsall CT, et al. Optimization of permeability in a series of pyrrolotriazine inhibitors of IRAK4. Bioorg. Med.Chem. 2018;26(4):913-24.
30. Sharif H, Wang L, Wang WL, Magupalli VG, Andreeva L, Qiao Q, et al. Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome. Nature. 2019;570(7761):338-43.
31. Pires DEV, Blundell TL, Ascher DB. pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. J. Med. Chem. 2015;58(9):4066-72.
32. Sander T, Freyss J, von Korff M, Rufener C. DataWarrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis. J. Chem. Inf. Model. 2015;55(2):460-73.
33. Su L-C, Xu W-D, Huang A-F. IRAK family in inflammatory autoimmune diseases. Autoimmun. Rev. 2020;19(3):102461.
34. Sendler M, van den Brandt C, Glaubitz J, Wilden A, Golchert J, Weiss FU, et al. NLRP3 inflammasome regulates development of systemic inflammatory response and compensatory anti-inflammatory response syndromes in mice with acute pancreatitis. Gastroenterology. 2020;158(1):253-69. e14.
|